Helix BioPharma Corp. (TSX:HBP)
2.800
-1.130 (-28.75%)
Oct 9, 2025, 3:59 PM EDT
Helix BioPharma Market Cap
Helix BioPharma has a market cap or net worth of CAD 300.17 million as of October 9, 2025. Its market cap has increased by 494.66% in one year.
Market Cap
300.17M
Enterprise Value
299.45M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.80
Market Cap Chart
Since August 15, 1995, Helix BioPharma's market cap has increased from 9.38M to 300.17M, an increase of 3,098.90%. That is a compound annual growth rate of 12.17%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 8, 2025 | 300.17M | 587.99% |
Dec 31, 2024 | 43.63M | -4.12% |
Dec 29, 2023 | 45.50M | 5.81% |
Dec 30, 2022 | 43.00M | 0.61% |
Dec 31, 2021 | 42.74M | -36.74% |
Dec 31, 2020 | 67.57M | -59.65% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Curaleaf Holdings | 3.35B |
Green Thumb Industries | 2.92B |
Trulieve Cannabis | 2.37B |
dentalcorp Holdings | 2.18B |
Sienna Senior Living | 1.76B |
WELL Health Technologies | 1.41B |
Cronos Group | 1.36B |
Extendicare | 1.24B |